Redsense Medical AB (publ)
Redsense Medical AB (publ) develops, markets, and sells monitoring systems for medical treatments primarily in Europe and the United States. The company offers Redsense System, a medical technology product that is used for monitoring and alarming in the event of blood leakage in connection with a hemodialysis treatment. It also provides Redsense Clamp, which clamps the bloodline to stop blood flo… Read more
Redsense Medical AB (publ) (RDSNF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2024: -0.159x
Based on the latest financial reports, Redsense Medical AB (publ) (RDSNF) has a cash flow conversion efficiency ratio of -0.159x as of June 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.81 Million) by net assets ($30.16 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Redsense Medical AB (publ) - Cash Flow Conversion Efficiency Trend (2019–2023)
This chart illustrates how Redsense Medical AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Redsense Medical AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Redsense Medical AB (publ) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cazaly Resources Ltd
AU:CAZ
|
-0.044x |
|
EV RESOURCES LTD.
F:R1EA
|
N/A |
|
Comet Industries Ltd
V:CMU
|
-0.002x |
|
Dataworks Group Ltd
AU:DWG
|
-32.658x |
|
Pan Asia Footwear Public Company Limited
BK:PAF
|
0.058x |
|
NINtec Systems Limited
NSE:NINSYS
|
N/A |
|
ISE Commerce Company Limited
KQ:069920
|
-0.080x |
|
REABOLD RESOURCES LS-001
F:AWL1
|
N/A |
Annual Cash Flow Conversion Efficiency for Redsense Medical AB (publ) (2019–2023)
The table below shows the annual cash flow conversion efficiency of Redsense Medical AB (publ) from 2019 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $23.09 Million | $-5.05 Million | -0.219x | +39.29% |
| 2022-12-31 | $27.15 Million | $-9.78 Million | -0.360x | -10.55% |
| 2021-12-31 | $37.49 Million | $-12.22 Million | -0.326x | -521.93% |
| 2020-12-31 | $73.20 Million | $-3.84 Million | -0.052x | +91.97% |
| 2019-12-31 | $14.95 Million | $-9.76 Million | -0.653x | -- |